Jun 26, 2025, 13:45
Dr Sthanu Subramanian: Tenecteplase VS Alteplase – TNK Targets the Fibrin in Blood Clots More Effectively
Dr. Sthanu Subramanian shared a post on X:
“Tenecteplase (TNK) vs. Alteplase (tPA):
TNK targets the fibrin in blood clots more effectively.
This means it is less likely to activate the body’s natural clotting system elsewhere, potentially reducing the risk of bleeding complications.”
Read also Dr Sthanu Subramanian Highlights EMS Protocols for Managing Atrial Fibrillation.
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026